EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis

Jingchun Huang, Lixin Gao, Liliia Glazutdinova, Xuyao Ji, Jing Zhang, Youmei Lu, Siyao Zhang, Yu Liu

Translational Oncology · 2026-07 · 69 · 102804

DOI: 10.1016/j.tranon.2026.102804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2026-07. Verfasst von Jingchun Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Harbin Medical University Affiliated Fourth Hospital, Harbin, Heilongjiang 150000, China. Electronic address: huan…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ARHGAP25BiomarkersBreast cancerINPP1OlinkProteomics

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Harbin Medical University Affiliated Fourth Hospital, Harbin, Heilongjiang 150000, China. Electronic address: huangjingchun397@163.com.
  • Department of Laboratory Medicine, Harbin Medical University Affiliated Fourth Hospital, Harbin, Heilongjiang 150000, China. Electronic address: 2024021914@hrbmu.edu.cn.
  • Department of Laboratory Medicine, Harbin Medical University Affiliated Fourth Hospital, Harbin, Heilongjiang 150000, China. Electronic address: Glazliliya@gmail.com.
  • Department of Laboratory Medicine, Harbin Medical University Affiliated Fourth Hospital, Harbin, Heilongjiang 150000, China. Electronic address: 1853239550@qq.com.
  • Department of Laboratory Medicine, Harbin Medical University Affiliated Fourth Hospital, Harbin, Heilongjiang 150000, China. Electronic address: 13854704223@163.com.
  • Department of Laboratory Medicine, Harbin Medical University Affiliated Fourth Hospital, Harbin, Heilongjiang 150000, China; Department of Laboratory Medicine, The 960th Hospital of the People's Liberation Army, Jinan,…

Zitieren

APA

Huang, J., Gao, L., Glazutdinova, L., Ji, X., Zhang, J., Lu, Y., Zhang, S., & Liu, Y. (2026). Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis. Translational Oncology, 69, 102804. https://doi.org/10.1016/j.tranon.2026.102804

Vancouver

Huang J, Gao L, Glazutdinova L, Ji X, Zhang J, Lu Y, et al. Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis. Translational Oncology. 2026;69:102804. doi:10.1016/j.tranon.2026.102804

BibTeX
@article{Huang2026,
  author = {Huang, Jingchun and Gao, Lixin and Glazutdinova, Liliia and Ji, Xuyao and Zhang, Jing and Lu, Youmei and Zhang, Siyao and Liu, Yu},
  title = {Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis},
  journal = {Translational Oncology},
  year = {2026},
  volume = {69},
  pages = {102804},
  doi = {10.1016/j.tranon.2026.102804}
}
Kostenlos starten →